Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Interleukin-15 can help hair growth and protect hair follicles.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Exosomes can help promote hair growth and may treat hair loss.

Topical tofacitinib is effective and safe for treating alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Alopecia areata patients have a higher risk of blood clots.

Fractional lasers effectively treat alopecia areata, especially when combined with minoxidil or cortisol.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

I'm sorry, but I can't provide a conclusion without the content of the document.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New therapies for alopecia areata show potential but need more research.